Skip to content

Characterizing the Impact of Presbyphonia on Social Interaction

Characterizing the Impact of Presbyphonia on Social Interaction

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06441136
Enrollment
25
Registered
2024-06-04
Start date
2025-01-10
Completion date
2026-08-31
Last updated
2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyphonia

Keywords

voice therapy, aging voice, voice disorder, speech

Brief summary

The purpose of this study is to determine if presbyphonia, or voice disorder caused by age-related change in the larynx, is associated with change in social interaction. This proposal investigates the impact of voice impairment in older adults on social interaction, loneliness, social disconnectedness, and depression. A series of questionnaires, voice assessments, and interviews will be performed to improve our understanding of how voice disorders affect older adults and how treatment of voice impairment with voice therapy may improve quality of life.

Detailed description

During the study visit, all subjects (including the control group) will be given ten questionnaires asking them to rate their loneliness and quality of life in relation to the changes in their voice. All participants will undergo audiometry to assess hearing (with hearing aids if used at home). If they do not pass the hearing test, they will be screened out of the study. Participants will then provide a required voice sample using sustained vowels for 3-5 seconds 5 times each, repeating six standard sentences, and 20 seconds of natural conversational speech. Using this voice recording, the following assessments and measurements will be obtained: CAPE-V rating (Consensus auditory perceptual evaluation of voice), Cepstral peak prominence (measurement of dysphonia), fundamental frequency, signal-to-noise ratio, and voice type components (captures breathiness). Subjects will then be asked to produce a train of /pi pi pi/ at a comfortable pitch and loudness into a mask with an intra-oral mouthpiece to record both pressure and airflow. Five trials will be performed. The following measurements will be obtained: mean flow rate, subglottal pressure, and vocal efficiency. Subjects will then undergo an awake videostroboscopy using a small flexible camera passed through the nose to view the vocal folds. During this procedure, the nose is anesthetized and the subject is asked to produce sustained vowels for 3-5 seconds. This part of the study takes about 2 minutes to complete. The parameters to be measured for this are: bowing index of the vocal folds and normalized glottal gap. For the second part of this study, subjects from the presbyphonia population only will be recruited to participate in the phonation resistance training exercises or PhoRTE voice therapy. Prior to therapy, for two weeks, participants will take pictures when their voice disorder may be affecting them or ability to socialize. Brief journal entry will be completed. Photos will be collected, printed, and used as memory recall tool for a pre-treatment semi-structured interview. Interviews will be conducted, approximately 45-60 minutes induration. Both online and in-person options will be available to facilitate participation. An interview guide will include questions designed to assess participants' perception of voice and how voice affects social participation. Subjects will then complete PhoRTE therapy. Participants perform 5 vocal exercises at individualized target vocal intensity. Goals of therapy are to increase muscular workload on vocal mechanism and target the respiratory and laryngeal muscular deficits that result from aging. Participants practice 6 days per week at home and meet with speech pathologist weekly for 4 weeks. Following therapy, participants will participate in 60-75-minute semi-structured small group interviews approximately 3 months after voice therapy. Interviews will address experience with voice therapy, and any changes after voice therapy.

Interventions

OTHERPhoRTE Program

Speech therapy program guided by a speech language pathologist. This program includes in person or virtual visits and at home exercises.

OTHERUniversity of California Los Angeles (UCLA) Loneliness Scale

A questionnaire measuring levels of loneliness.

OTHERSocial Disconnectedness Scale

A questionnaire that asks about social network size and the frequency of social activities attended.

A questionnaire measuring levels of depression.

OTHERAging Voice Index

A questionnaire of patient-reported voice outcome measures designed to capture the quality of life impact of dysphonia in older adults.

OTHERThe Edmonton Frail Scale

A questionnaire that measures frailty levels.

OTHERVocal Effort Scale

A picture based questionnaire scale that asks the subject to rate their perceived effort when using their voice.

A screening tool used to test for cognitive impairment.

A questionnaire used to measure quality of life impact of dysphonia.

OTHERVoice Problem Impact Scales

A 4 question survey that captures impact of voice on four domains - work/daily activities, social life, home, and overall quality of life.

OTHERCough Severity Index

A 10 question survey asking to rate severity of cough.

PROCEDURELaryngoscopy

Nose is anesthetized and a flexible endoscope is passed to visualize the larynx at rest and during sustained vowel production (/i/) for 3-5 seconds. This will be used to measure bowing index and normalized glottal gap of the vocal folds.

OTHERAcoustic, perceptual, and aerodynamic assessments

Participants will complete voice recording tasks including sustained vowel production, six standard sentences, and 20 seconds of natural conversational speech. This will be used to measure CAPE-V rating, Cepstral peak prominence, fundamental frequency, signal-to-noise ratio, voice type components, mean flow rate, subglottal pressure, and vocal efficiency.

Sponsors

Matthew R. Hoffman
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of presbyphonia with findings of presbylaryngis on videostroboscopy, with findings of bilateral true vocal fold atrophy and normal vocal fold motion bilaterally * Able to complete all questionnaires and voice assessment tasks * Normal to mild hearing loss in aided condition (with hearing aids)

Exclusion criteria

* Liquid dysphagia or pneumonia in the last year * Vocal fold lesion/scar/motion impairment * Neurologic disorder affecting the voice * Montreal cognitive assessment score \<26 or \<25 if 12 or fewer years of formal education

Design outcomes

Primary

MeasureTime frameDescription
The Effect on Loneliness with the PhoRTE Voice Therapy ProgramBaseline and at 3 monthsLoneliness will be measured using the University of California - Los Angeles (UCLA) Loneliness Scale questionnaire at baseline and at the end of the 4-week PhoRTE program. The UCLA Loneliness Scale is a 20-item scale with each item rated on a 4-point Likert scale (ranging from 1, never, to 4, often) and the total score can range from 20 to 80, with higher scores indicating greater feelings of loneliness.

Secondary

MeasureTime frameDescription
The Effect on Social Disconnectedness with the PhoRTE Voice Therapy ProgramBaseline and at 3 monthsSocial disconnectedness will be measured using the Social Disconnectedness Scale questionnaire at baseline and at the end of the 4 week PhoRTE program. The Social Disconnectedness Scale is based on a 15-item scale with each item rated on their own scale depending on the question asked (ex: ranging from 0, never to 7, several times a week or indicating number of individuals in a social network). The total score can range from 2 to 72, with lower scores indicating greater levels of social disconnectedness.
The Effect on Depression with the PhoRTE Voice Therapy ProgramBaseline and at 3 monthsLevels of depression will be measured using the Patient Health Questionnaire-9 (PHQ-9) at baseline and at the end of the 4 week PhoRTE program. The PHQ-9 is a 9-item scale with each item rated on a scale (ranging from 0, not at all, to 3, nearly every day) and the total score can range from 0-27 with higher scores indicating greater feelings of depression.

Countries

United States

Contacts

Primary ContactMatthew R Hoffman, MD, PhD
matthew-r-hoffman@uiowa.edu319-356-2201
Backup ContactEmma L Thayer, BS
emma-thayer@uiowa.edu319-678-7518

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026